Abivax stock plummeted Tuesday after several patients developed cancer following a study of its ulcerative colitis treatment.

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this 12-part journey ...

Abivax (ABVX) plunged in premarket trading on Tuesday despite announcing positive Phase 3 maintenance trial results for its ...

Shares in French biotech Abivax tumbled more than 30% today, after it announced phase 3 data with ulcerative colitis (UC) ...

A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today highlighted the publication ...

Eugenia Uche-Anya, MD, MPH, gastroenterology fellow at Massachusetts General Hospital, discusses the results of the case and important points to keep in mind when treating patients with mild UC: ...

Sujaata Dwadasi, MD, an IBD Specialist at Carle Foundation Hospital in Illinois, discusses the baseline characteristics of the case: “It starts with a 35-year-old female with no significant past ...